APOE and Alzheimer disease: Homozygous individuals for the ApoE4 alleles have a greater than 50% risk for the AD phenotype, while for a heterozygous individual, the risk reduces to something between 20% and 30%.(77) The most common mechanism by which ApoE4 participates in AD development is increasing the aggregation of beta-amyloid plaques and reducing their clearance.